Cost saving must be a re-investment in manufacturing processes, ie, automation. Cost saving should not be sending operations overseas for a "quick fix". The investment of sending surgical instrumentation to China will prove to be a cost increase and is not viewed by the public as being a reinvestment in America. Stryker's transfer of product to China was an answer to Zimmer and was a copycat manuver to apease stock holders. The thought of opening up China as a customer is doubtful.
Still no new ceo: stryker is trying to save money till next year because it seems no guidance is actually needed at this time. Stryker is on the defensive it seems. (don't do anything new and you won't get in trouble)